CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
Abstract Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective aga...
Guardado en:
Autores principales: | Kenta Tsunekuni, Masamitsu Konno, Naotsugu Haraguchi, Jun Koseki, Ayumu Asai, Kazuaki Matsuoka, Takashi Kobunai, Teiji Takechi, Yuichiro Doki, Masaki Mori, Hideshi Ishii |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57752e7b4a7f4f24852730100fc831b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-molecule RNA sequencing for simultaneous detection of m6A and 5mC
por: Takahito Ohshiro, et al.
Publicado: (2021) -
Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Ingrīda Čēma, et al.
Publicado: (2021) -
Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells
por: Ni MZ, et al.
Publicado: (2015) -
Prognostic impact of CD133 expression in Endometrial Cancer Patients
por: G. Mancebo, et al.
Publicado: (2017) -
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Gul-e-Saba Chaudhry, et al.
Publicado: (2020)